Featured Research

from universities, journals, and other organizations

Bedouin tribe reveals secrets to 'GA-JOE' high-tech genome analyzer

Date:
September 30, 2010
Source:
McGill University
Summary:
Scientists studied three patients from biologically interrelated Bedouin families, and sent samples to Canada for analysis by GA JOE -- a high-tech genome analyzing machine. They discovered that mutations in the gene SCARF2 are responsible for Van Den Ende-Gupta syndrome.

A Genome Quebec staff scientist prepares GA-JOE for genetic analysis work.
Credit: G้nome Qu้bec, Montr้al

Van Den Ende-Gupta syndrome (VDEGS) is an extremely rare genetic disorder that is characterized by distinctive head and facial features, such as unusual eyelids, narrow and beaked noses, flat nasal bridges, jaw deformities, and a turned out lower lip. As part of McGill's "RaDiCAL" project (Rare Disease Consortium for Autosomal Loci), collaborators in Qatar conducted field research with three patients from biologically interrelated Bedouin families, and sent samples to Canada for analysis by GA JOE -- a high-tech genome analyzing machine.

The research effort was led by husband and wife team Dr. Jacek Majewski and Dr. Loydie A. Jerome-Majewska, both of McGill University's Department of Human Genetics and the Research Institute of the McGill University Health Centre. The team discovered that mutations in the gene SCARF2 are responsible for the condition, and published their findings online September 30 in the American Journal of Human Genetics.

"Why is this interesting? One of my roles at McGill is to implement new genomic technologies in human genetics research," explained Majewski. "Essentially, with a new technique known as exome capture and sequencing, we can now quickly sequence all of the coding portions of the human genome. This approach allows us to identify mutations responsible for rare genetic disorders. While they were too rare to attract much interest, these disorders hold in fact a lot of promise for the identification of the genes and pathways that are involved in generating human diversity. Moreover, knowing the mutations will be essential for future genetic testing and potential therapeutic intervention."

SCARF2 may for instance be involved in DiGeorge Syndrome, a much more common disorder affecting 1:3000 live births. DiGeorge syndrome causes deformities such as congenital heart defects. The researchers caution however that drawing links at this stage amounts to nothing more than "tantalizing speculation."

In anticipation of the fast advances in technology, McGill is identifying as many of the genes responsible for rare disorders as possible. "Over the past couple of years we've been identifying collaborators worldwide and collecting patients and DNA samples for mutation hunting," Majewski said. "This is one of the earliest successes of this project, which is still a hybrid of old and new technologies. In this particular case, although we found the mutation the old fashioned way, we had immediate confirmation using exome sequencing."

"To me the current manuscript is an early example of the enormous power of new exome/genome sequencing approaches and of the involvement of McGill researchers in this field," Majewski concluded. "It really is a harbinger of more to come."

This research received funding from the Canada Institutes for Health Research, the Research Institute of the McGill University Health Centre, and a Canada Research Chair award to Majewski. Field research was carried out by the Qatar Medical Genetic Center. Led by Dr. Tawfeg Ben-Omran, the Qatar Medical Genetic Center is staffed by expert clinical geneticists and dysmorphologists, who have developed specific areas of expertise, providing a foundation for excellent family-centred care. The sequencing was carried out in close collaboration with the staff of the Genome Quebec sequencing facility.


Story Source:

The above story is based on materials provided by McGill University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Natascia Anastasio, Tawfeg Ben-Omran, Ahmad Teebi, Kevin C.H. Ha, Emilie Lalonde, Rehab Ali, Mariam Almureikhi, Vazken M. Der Kaloustian, Junhui Liu, David S. Rosenblatt. Mutations in SCARF2 Are Responsible for Van Den Ende-Gupta Syndrome. The American Journal of Human Genetics, 2010; DOI: 10.1016/j.ajhg.2010.09.005

Cite This Page:

McGill University. "Bedouin tribe reveals secrets to 'GA-JOE' high-tech genome analyzer." ScienceDaily. ScienceDaily, 30 September 2010. <www.sciencedaily.com/releases/2010/09/100930143349.htm>.
McGill University. (2010, September 30). Bedouin tribe reveals secrets to 'GA-JOE' high-tech genome analyzer. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2010/09/100930143349.htm
McGill University. "Bedouin tribe reveals secrets to 'GA-JOE' high-tech genome analyzer." ScienceDaily. www.sciencedaily.com/releases/2010/09/100930143349.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins